RAB25 and cancer: Studies have reported that the dysregulation of RAB25 gene expression could be associated with the aggressiveness of various human cancers, including breast and ovarian cancers [18, 19], prostate cancer [20], bladder carcinoma [21], lung cancer [22], bladder cancer [21], gastric carcinoma [23], head and neck cancer [24, 25], and esophageal carcinoma [26].